| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | | Total Revenue | 1,396,678 | 1,256,666 | | Cost of Revenue | 961,570 | 867,733 | | | Gross Profit | 435,108 | 388,933 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 348,879 | 320,616 | | Non Recurring | 602 |
-
| | Others | 15,984 |
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 69,643 | 68,317 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 15 | (21,842) | | Earnings Before Interest And Taxes | 69,658 | 46,475 | | Interest Expense | 7,103 | 10,706 | | Income Before Tax | 62,555 | 35,769 | | Income Tax Expense | 26,058 | 14,363 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 36,497 | 21,406 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 36,497 | 21,406 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $36,497 | $21,406 |
|